Rationale: Chronically critically ill patients are often dependent on family members for surrogate decision-making, and these surrogates are at high risk for emotional distress. We hypothesized that patientand surrogate-specific risk factors for surrogate post-traumatic stress disorder (PTSD) symptoms can be identified early in the course of chronic critical illness.
Chronic critical illness (CCI) is a syndrome characterized by prolonged dependence on life-sustaining therapies after resolution of the acute phase of organ failure (1) . Estimates of 1-year mortality range between 50% and 60%, and of those patients who require prolonged mechanical ventilation (PMV) and are alive at the end of 1 year, only 10% will be living at home with functional independence (2) . Critical illness represents a major life-altering event, and is often fraught with a series of decisions that must be made regarding invasive, lifesustaining therapies. However, because of ongoing cognitive dysfunction (3), chronically critically ill patients are rarely capable of communication and decisionmaking in the intensive care unit (ICU). As such, many patients with CCI become dependent upon family members to assist with decision-making about life-sustaining care.
Acting as a family surrogate decisionmaker is associated with a number of negative consequences, including a subjective sense of overload and burden, emotional distress, and poor health-related quality of life (4, 5) . Specific stressors that surrogate decision-makers frequently identify include uncertainty regarding the patient's prognosis, perception of conflict with the provider team, and a sense of guilt surrounding medical decisions (6) . Perhaps as a result, anxiety, depression, and posttraumatic stress disorder (PTSD) have all been described in family decision-makers of patients with critical illness (4, 7) . One longitudinal cohort study found that 35% of family surrogates experienced symptoms of post-traumatic stress 6 months after a loved one's admission to the ICU, as compared with 15% who experienced anxiety and 6% who experienced depression (8) . When comparing patient-caregiver dyads, symptoms of PTSD are higher and persist for longer in the caregivers (9) . Identifying potential risk factors for surrogate PTSD symptoms early in the course of a loved one's CCI could enable physicians, nurses, and social workers to more effectively target support services toward those at highest risk.
Given that PTSD symptoms are common and persistent among surrogates for patients with CCI, we sought to identify potential risk factors present early in the course of CCI that can help identify family members who might benefit from early intervention. We hypothesized that both patient-specific and surrogate decisionmaker-specific risk factors for surrogate PTSD symptoms at 90 days can be identified on Day 10 of patient mechanical ventilation.
Methods
We performed a secondary analysis of the data from a multicenter, randomized, controlled trial to determine whether family informational and support meetings would improve emotional outcomes for family surrogates of patients with CCI when compared with routine care (10) . We enrolled patients from two tertiary care centers and a community hospital in the Southeastern United States and an urban tertiary care center in the Northeastern Surrogate symptoms of anxiety and depression were assessed at the time of enrollment using the Hospital Anxiety and Depression Scale (HADS) (16, 17) . The HADS is a validated instrument designed to measure symptoms of anxiety and depression in hospitalized patients, and has been used for family subjects in the ICU setting (7) . The HADS consists of two subscales (anxiety and depression), each containing seven items with a score ranging from 0 (lowest level of symptoms) to 3 (highest level of symptoms). A score of 11 or greater on either subscale suggests the presence of anxiety and/or depression disorder(s); scores from 8 to 10 may represent "borderline" symptom levels. Additional information on available variables can be found in descriptions of the clinical trial (10).
Primary Outcome Measure
The presence and severity of surrogate PTSD symptoms were defined using the Impact of Events Scale-Revised (IES-R), a validated instrument that has been used to evaluate the experience of families of ICU survivors and nonsurvivors (18, 19) . The IES-R includes 22 items in 3 subscales, thought intrusion, avoidance, and hyperarousal, rated for "how distressing each difficulty has been" over the past 7 days from 0 (not at all) to 4 (extremely). Subscales are scored individually (mean of item scores) and then summed. Total scores for IES-R range from 0 to 88; a score of 33 or greater is a cut-off used to suggest PTSDrelated symptoms at a level consistent with a probable diagnosis of PTSD. The IES-R was administered to all available enrolled surrogate decision-makers beginning 90 days after study enrollment.
Statistical Analyses
Descriptive statistics were analyzed using mean and 95% confidence interval (CI) for Table 1 . About one-half of the patients (49%) were female and were slightly older than surrogates, with a mean age of 59 years. Mean ADL score in the 2 weeks before hospital admission was 5 (95% CI, 4.6-5.2), indicating relatively high functionality. Liver disease (24%) and cancer (13%) were the most common comorbid conditions, and 1-year mortality risk, as estimated by the ProVent14 score, was 62% (95% CI, 58.6-64.8). Complete patient characteristics are shown in Table 2 .
Preselected patient-and surrogaterelated characteristics were then assessed for association with 90-day surrogate IES-R score. A complete list of variables included in the analysis is shown in Table 3 (surrogate characteristics) and Table 4 (patient characteristics), along with the associated Figure 1 . In a post hoc sensitivity analysis, Day 10 HADS score remained a risk factor for surrogate PTSD symptoms even after adjusting for events that occurred later in the ICU stay or after hospital discharge, including death by the time of 90-day surrogate interview and study group from the clinical trial (coefficient = 1.08; 95% CI, 0.81-1.35).
Discussion
In this analysis of potential risk factors for PTSD symptoms in surrogate decisionmakers of patients with CCI, surrogate anxiety and depression (HADS score) and patient unresponsiveness on or near Day 10 of mechanical ventilation were risk factors for increased surrogate PTSD symptoms at 90 days. No variables pertaining to surrogate or patient demographics, premorbid patient health status, or events of the hospitalization before ICU admission were found to be significant. HADS is a simple scale that can be administered to family members in a few minutes, and level of arousal and responsiveness is routinely assessed in all patients.
Family surrogate decision-makers with higher HADS scores near Day 10 of mechanical ventilation, especially when their loved one is unresponsive while they are at the bedside, can be targeted for early interventions to help them cope with severe illness and decision-making. Interventions to reduce long-term emotional distress in surrogate decision-makers have met with limited success in rigorous clinical trials to date (10, (19) (20) (21) (22) . Targeting those individuals who are at highest risk and implementing interventions early in the course of CCI could enhance the success of such interventions, and this could be facilitated by using the risk factors identified in this study. A simple means to identify higherrisk family decision-makers could also help to deploy intervention resources in a more focused and efficient manner.
The finding that unresponsiveness remained a risk factor even after adjusting for HADS is an interesting one for which there are several possible explanations. A RASS score of 24 or 25 at Day 10 of mechanical ventilation could reflect deep sedation due to severe hypoxemia or ventilator dyssynchrony, or due to advanced encephalopathies related to underlying acute diseases. Trauma patients were excluded from the clinical trial, and acute cerebral vascular events were unusual in this medical ICU population. One explanation for this finding is that unresponsiveness is a surrogate for advanced illness and poor prognosis. However, other illness severity measures were not significantly associated. Another explanation is that a patient's unresponsiveness over days is an extremely distressing experience for the family, secondary to either the fact that it is an overt and constant reminder of the critical nature of their loved one's illness, and/or the fact that it places a heavier burden on the surrogate decision-maker without guidance from the patient (23).
Our findings provide novel insight into the identification of surrogates at highest risk for emotional distress after a loved one's discharge from the ICU. A 2005 study of caregivers in the general ICU population in France measured a limited number of variables, and found that female sex, cancer Definition of abbreviations: ADLs = activities of daily living; CI = confidence interval; ESRD = end-stage renal disease; HADS = Hospital Anxiety and Depression Scale; iADLs = instrumental activities of daily living; IES-R = Impact of Events Score-Revised; RASS = Richmond Agitation Sedation Scale. Em dash (-) indicates reference group. *All models were adjusted for multiple respondents. † For continuous variables, the coefficient represents mean change in IES-R score per one-unit increase. For categorical variables, the coefficient represents mean difference in IES-R score as compared to the reference group. ‡ P , 0.05. x Model includes primary surrogate decision-makers only.
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in the ICU patient, and being a child of the ICU patient were independently associated with increased risk for post-traumatic stress symptoms, but, as CCI represents a distinct syndrome with a potentially separate profile for long-term surrogate distress, these findings may not be generalizable to the CCI population. Reliance on these demographic factors alone to identify surrogates at risk for heightened PTSD symptoms could result in omission of high-risk surrogates in other categories, such as high-risk male surrogates. Furthermore, some of the factors identified in that study, such as surrogate perception that information was incomplete or patient death in the ICU, occur later in the course of critical illness, and thus represent less useful targets for screening and intervention during the patient's ICU course. Another study of a Greek cohort of family caregivers for patients admitted to the ICU found that female sex and baseline anxiety were significant joint predictors of the development of PTSD symptoms before hospital discharge, although this study was limited by small sample size with just 32 caregivers (24) . Investigation of a German cohort found that higher relationship satisfaction between the patient and the surrogate was protective against post-traumatic stress in the CCI population, but this study was limited by low follow-up rate with only 12% of enrolled patient-surrogate dyads available for 6 month follow-up (25) . A recent study by Torke and colleagues (26) demonstrated that baseline distress, as measured by the Kessler six-item Psychological Distress Scale, was positively associated with post-traumatic stress at 6-8 weeks after hospitalization for family surrogate decision-makers of older adults admitted to either the ICU or the general wards. As compared with the population in this study, our patients had a much higher severity of illness and worse long-term outcomes, and family members had a more significant degree of PTSD symptoms. This secondary analysis is based on the largest completed randomized, controlled trial of patients with CCI and surrogates to date, thus providing a rich dataset and a unique opportunity to explore potential risk factors for surrogate PTSD in this population.
Our study has several limitations. The observational nature of the analysis limits our ability to fully elucidate the cause-andeffect nature of the observed risk factors and the outcome of interest. In addition, because we are unable to measure PTSD symptoms before patients' hospital admission, we do not know whether surrogates experienced ORIGINAL RESEARCH
